Sign Up Today and Learn More About Beacon Therapeutics Stock
Invest in or calculate the value of your shares in Beacon Therapeutics or other pre-IPO companies through EquityZen's platform.
Beacon Therapeutics Stock (BETH)
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
About Beacon Therapeutics Stock
Founded
2023
Industries
Software, Artificial Intelligence, Data and Analytics
Beacon Therapeutics Press Mentions
Stay in the know about the latest news on Beacon Therapeutics
QuotedData’s morning briefing 9 December 2024 – JEDT, BBH, OIG, SYNC
quoteddata • Dec 09, 2024
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial of laru-zova (AGTC-501) in Patients with X-Linked Retinitis Pigmentosa (XLRP)
biospace • Dec 09, 2024
Syncona's Beacon Therapeutics presents trial results at conference
marketscreener • Sep 20, 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
prnewswire • Aug 03, 2024
Beacon Therapeutics Raises $170M in Series B Funding
finsmes • Aug 03, 2024
Beacon Therapeutics Management
Leadership team at Beacon Therapeutics
Board Member
Cariad Chester
Board Member
Wouter Joustra
Join now and verify your accreditation status to gain access to:
- Beacon Therapeutics current valuation
- Beacon Therapeutics stock price
- Available deals in Beacon Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Beacon Therapeutics Stock
How to invest in Beacon Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Beacon Therapeutics through EquityZen funds. These investments are made available by existing Beacon Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Beacon Therapeutics stock?
Shareholders can sell their Beacon Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
